SecBot SecBot
S-3ASR ·Filed Jun 26, 2026

SYRE

Spyre Therapeutics, Inc.
NEUTRAL
Impact 5/10
Horizondays Processed4mo ago SEC0001628280-26-045742
Notable filing: S-3ASR
Actionable Insight • Neutral

LLM returned non-JSON response. Review the filing manually.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$90.16
T+0 close · Jun 26, 2026 · via day close
Latest settled
+2.01%
T+60 · $91.97
Vs SPY
−2.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 29 $90.16entry
  2. T+1 · 5mo ago −1.53%α −2.31% · $88.78
  3. T+5 · 4mo ago −1.57%α −2.96% · $88.74
  4. T+20 · 4mo ago +13.28%α +13.56% · $102.13
  5. T+60 · 8w ago +2.01%α −2.38% · $91.97
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

{ "summary": "Spyre Therapeutics filed an automatic shelf registration statement (S-3ASR) on June 26, 2026, registering an unlimited amount of securities, and concurrently entered into a $500M at-the-market (ATM) sales agreement with TD Cowen for common stock. The company has a $7.8B market cap, a strong cash position from prior raises, and no disclosed need for immediate capital, making this an opportunistic shelf filing to maintain financial flexibility rather than a distress-driven raise.",

Financial Impact

Unknown

Risk Factors

  • Analysis may be incomplete

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3ASR Filing (Primary)0001628280-26-045742
Exhibit: exhibit12-sx3asr.htm0001628280-26-045742
Exhibit: exfilingfees-s3asr.htm0001628280-26-045742
Exhibit: exhibit51-sx3asr.htm0001628280-26-045742
Exhibit: exhibit52-sx3asr.htm0001628280-26-045742
Exhibit: exhibit232-sx3asr.htm0001628280-26-045742
Exhibit: exhibit231-sx3asr.htm0001628280-26-045742
Document: spyre-formsx3asrjune2026.htm0001628280-26-045742

Track record

36 reports on SYRE

Performance horizon

8 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 15 of 21 went positive at some point.

Filters
  1. Nov 3, 202613d ago 8-K Neutral 5/10 No price data
  2. Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
  3. Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
  4. Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
  5. Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
  6. Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
  7. Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  8. Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  9. Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  10. Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
Showing 10 of 36

US Market Status

Market Closed · Opens in 7h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026